Global Neuraminidase Inhibitor Market Report By Drug Type (Zanamivir, Oseltamivir, Peramivir, Laninamivir), By Route of Administration (Oral, Nasal, Parenteral), By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Stores, Others)And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11212068
April 2020
Report Formats:

The global demand for Neuraminidase Inhibitor Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Neuraminidase inhibitors are antiviral drugs that function to block influenza virus, by preventing reproduction by budding from the host cell, limit the spread of the virus within the respiratory tract and prevent virus penetration of respiratory secretions to initiate replication. These drugs inhibit all subtypes of neuraminidase enzymes, and are effective at preventing and treating influenza, are taken within 48 hours of the onset of symptoms.  Oseltamivir, zanamivir, peramivir, and zanamivir are some common examples of neuraminidase inhibitor drugs. 
 
Market Dynamics
 
Growing incidence of influenza infection is driving the growth of the market. All age groups are affected each year, developing in approximately 20 % of the world's population. Neuraminidase inhibitor is recommended as a drug treatment option for COVID-19. At present, there is no vaccine or treatment for coronavirus, so identifying the drug treatment options as soon as possible is critical for the response to the COVI-19 outbreak. Neuraminidase inhibitor is discovered to have the potential antiviral treatment of human pathogen coronavirus.  This brings an opportunity for growth. However, the efficacy and safety of these drugs for COVID-19 still need to be further confirmed by clinical experiments. Observational studies are still ongoing. Favourable results are expected to hold a large revenue share in the neuraminidase inhibitors market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Neuraminidase Inhibitor.
 
Market Segmentation
 
The entire Neuraminidase Inhibitor market has been sub-categorized into drug type, route of administration, and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Drug Type

  • Zanamivir
  • Oseltamivir
  • Peramivir
  • Laninamivir
 
By Route of Administration
  • Oral
  • Nasal
  • Parenteral
 
By Distribution Channel
  • Hospital Pharmacies
  • Drug Stores
  • Retail Stores
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for Neuraminidase Inhibitor market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Neuraminidase Inhibitor Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Neuraminidase Inhibitor market include GlaxoSmithKline, Gilead Sciences, F. Hoffman-La Roche, BioCryst Ltd. and Daiichi Sankyo Co. Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Neuraminidase Inhibitor Market
       2.2. Global Neuraminidase Inhibitor Market Snapshot
 
3 . NEURAMINIDASE INHIBITOR – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Neuraminidase Inhibitor Market
       3.3. Market Restraints of Neuraminidase Inhibitor Market
       3.4. Opportunities of Neuraminidase Inhibitor Market
       3.5. Trends of Neuraminidase Inhibitor Market
       3.6. Porter’s Five Force Analysis of Neuraminidase Inhibitor Market
       3.7. Neuraminidase Inhibitor Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug Type
           3.7.2 Market Attractive Analysis by Route of Administration
           3.7.3 Market Attractive Analysis by Distribution Channel
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Neuraminidase Inhibitor Value Chain Analysis
       4.2. Neuraminidase Inhibitor Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Neuraminidase Inhibitor Raw Material Manufactures List
           4.2.3. Price Trend of Neuraminidase Inhibitor Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL NEURAMINIDASE INHIBITOR MARKET ANALYSIS BY DRUG TYPE
       5.1 Overview by Drug Type
       5.2 Global Neuraminidase Inhibitor Market Analysis by Drug Type
       5.3 Market Analysis of Zanamivir by Regions
       5.4 Market Analysis of Oseltamivir by Regions
       5.5 Market Analysis of Peramivir by Regions
       5.6 Market Analysis of Laninamivir by Regions
 
6 . GLOBAL NEURAMINIDASE INHIBITOR MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       6.1 Overview by Route of Administration
       6.2 Global Neuraminidase Inhibitor Market Analysis by Route of Administration
       6.3 Market Analysis of Oral by Regions
       6.4 Market Analysis of Nasal by Regions
       6.5 Market Analysis of Parenteral by Regions
 
7 . GLOBAL NEURAMINIDASE INHIBITOR MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Global Neuraminidase Inhibitor Market Analysis by Distribution Channel
       7.3 Market Analysis of Hospital Pharmacies by Regions
       7.4 Market Analysis of Drug Stores by Regions
       7.5 Market Analysis of Retail Stores by Regions
       7.6 Market Analysis of Others by Regions
 
8 . GLOBAL NEURAMINIDASE INHIBITOR MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Neuraminidase Inhibitor Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Neuraminidase Inhibitor Market Estimate by Market Segment
           8.4.3. Europe Neuraminidase Inhibitor Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Neuraminidase Inhibitor Market Estimate by Market Segment
           8.5.3. Asia Pacific Neuraminidase Inhibitor Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Neuraminidase Inhibitor Market Estimate by Market Segment
           8.6.3. Latin America Neuraminidase Inhibitor Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Neuraminidase Inhibitor Market Estimate by Market Segment
           8.7.3. Middle East & Africa Neuraminidase Inhibitor Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE NEURAMINIDASE INHIBITOR COMPANIES
       9.1. Neuraminidase Inhibitor Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF NEURAMINIDASE INHIBITOR INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. GlaxoSmithKline
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Gilead Sciences
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. F. Hoffman-La Roche
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. BioCryst Ltd.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Daiichi Sankyo Co. Ltd.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Neuraminidase Inhibitor Market Snapshot
  • Drivers of The Global Neuraminidase Inhibitor Market Impact Analysis
  • Restraints of The Global Neuraminidase Inhibitor Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Zanamivir by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Oseltamivir by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Peramivir by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Laninamivir by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis by Route of Administration (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Oral by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Nasal by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Parenteral by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis by Distribution Channel (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Drug Stores by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Retail Stores by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Others by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market by Geography (USD MN)
  • North America Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • North America Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • North America Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • North America Neuraminidase Inhibitor Market Estimate by Country (USD MN)
  • United State Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • United State Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • United State Neuraminidase Inhibitor Market Analysis by Distribution Channel (USD MN)
  • Rest of North America Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Rest of North America Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Rest of North America Neuraminidase Inhibitor Market Estimate by Distribution Channel(USD MN)
  • Europe Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Europe Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Europe Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • United Kingdom Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • United Kingdom Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • France Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • France Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • France Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Germany Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Germany Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Germany Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Rest of Europe Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Rest of Europe Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Asia Pacific Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Asia Pacific Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Neuraminidase Inhibitor Market Estimate by Country (USD MN)
  • China Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • China Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • China Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Japan Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Japan Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Japan Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • India Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • India Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • India Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Rest of Asia Pacific Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Rest of Asia Pacific Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Latin America Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Latin America Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Latin America Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Latin America Neuraminidase Inhibitor Market Estimate by Country (USD MN)
  • Brazil Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Brazil Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Brazil Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Rest of Latin America Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Rest of Latin America Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Middle East & Africa Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Middle East & Africa Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Neuraminidase Inhibitor Market Estimate by Country (USD MN)
  • Middle East Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Middle East Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Middle East Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Africa Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Africa Neuraminidase Inhibitor Market Estimate by Route of Administration (USD MN)
  • Africa Neuraminidase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Neuraminidase Inhibitor Report
  • Market Research Process
  • Market Research Methodology
  • Global Neuraminidase Inhibitor Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Type
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Neuraminidase Inhibitor Market Analysis by Drug Type (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Zanamivir by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Oseltamivir by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Peramivir by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Laninamivir by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis by Route of Administration (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Oral by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Nasal by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Parenteral by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis by Distribution Channel (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Drug Stores by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Retail Stores by Geography (USD MN)
  • Global Neuraminidase Inhibitor Market Analysis in Others by Geography (USD MN)
  • Latin America Neuraminidase Inhibitor Market by Revenue
  • Middle East & Africa Neuraminidase Inhibitor Market by Revenue
  • Recent Development in Neuraminidase Inhibitor Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials